Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Dr Ceferino Obcemea joined Radiation Research, National Cancer Institute (NCI) in 2017 as Program Director in Medical Physics. He oversees a portfolio of grants that includes all aspects of clinical physics in radiation oncology, novel medical devices, new treatment modalities such as ion beam therapy, on-line imaging techniques as well as the emerging fields of AI applications in radiotherapy, Big Data analytics and machine learning. He also serves as the NCI medical physics liaison to the various clinical trial groups comprising the National Clinical Trials Network (NCTN).

Prior to coming to NCI, Dr. Obcemea had many years of experience as chief physicist at Memorial Sloan Kettering Cancer Center (Westchester campus NY), Beth Israel Medical Center in New York City, and Georgetown University (Frederick campus). He received his clinical training at the Joint Center for Radiation Therapy, Harvard Medical School in Boston and is board-certified by the American Board of Radiology.

Dr. Obcemea completed his Ph.D. in Physics from Uppsala University, Sweden in the fields of many-body scattering theory and non-equilibrium quantum statistical mechanics. He received various research fellowships from the Svenska Institutet (Stockholm), Niels Bohr Institute (Copenhagen), International Center for Theoretical Physics, ICTP (Trieste) and the Quantum Theory Project (QTP) at the University of Florida, Gainesville, among others.

His current interests include machine designs for more affordable, compact, more robust accelerators, harmonization of clinical trial databases for discovery extraction and machine learning, radiomics for radiation oncology, new treatment regimens with particle beams, and biomedical applications of quantum computing and quantum sensing.

Selected Publications

Education

  • Ph.D. Physics (non-equilibrium statistical mechanics, many-body scattering) Uppsala University, Uppsala, Sweden
  • Postdoctoral clinical training, Harvard Medical School, Boston, MA
Email